Get started
Genetic Technologies Ltd.Genetic Technologies Ltd.Genetic Technologies Ltd.

Genetic Technologies Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

GNTLF chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪10.58 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0841USD
Net income (FY)
‪−7.83 M‬USD
Revenue (FY)
‪5.78 M‬USD
Shares float
‪132.22 M‬
Beta (1Y)
2.03

About GENETIC TECHNOLOGIES LIMITED

Sector
Health Technology
Industry
Biotechnology
CEO
Simon Morriss
Website
genetype.com
Headquarters
Fitzroy
Employees (FY)
60
Founded
1987
ISIN
AU000000GTG7
FIGI
BBG000MKLWF0
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GNTLF is 0.0700 USD — it has decreased by 98.90% in the past 24 hours. Watch Genetic Technologies Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Genetic Technologies Ltd. stocks are traded under the ticker GNTLF.
GNTLF reached its all-time high on Aug 19, 2003 with the price of 52.5000 USD, and its all-time low was 0.0100 USD and was reached on Dec 16, 2020. View more price dynamics on GNTLF chart.
See other stocks reaching their highest and lowest prices.
GNTLF stock is ‪8.96 K‬% volatile and has beta coefficient of 2.03. Track Genetic Technologies Ltd. stock price on the chart and check out the list of the most volatile stocks — is Genetic Technologies Ltd. there?
Today Genetic Technologies Ltd. has the market capitalization of ‪10.58 M‬, it has increased by 2.14% over the last week.
Yes, you can track Genetic Technologies Ltd. financials in yearly and quarterly reports right on TradingView.
Genetic Technologies Ltd. is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
Genetic Technologies Ltd. revenue for the last quarter amounts to ‪2.69 M‬ USD despite the estimated figure of ‪2.86 M‬ USD. In the next quarter revenue is expected to reach ‪3.00 M‬ USD.
GNTLF net income for the last quarter is ‪−4.37 M‬ USD, while the quarter before that showed ‪−4.19 M‬ USD of net income which accounts for −4.31% change. Track more Genetic Technologies Ltd. financial stats to get the full picture.
No, GNTLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 21, 2024, the company has 60.00 employees. See our rating of the largest employees — is Genetic Technologies Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Genetic Technologies Ltd. EBITDA is ‪−6.21 M‬ USD, and current EBITDA margin is −127.66%. See more stats in Genetic Technologies Ltd. financial statements.
Like other stocks, GNTLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genetic Technologies Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genetic Technologies Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genetic Technologies Ltd. stock shows the strong sell signal. See more of Genetic Technologies Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.